Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. GS-5816 demonstrated pangenotypic antiviral activity in patients with genotype 1-4 HCV infection. It will be further evaluated in combination with other pangenotypic direct-acting antivirals to achieve the goal of developing a well-tolerated, highly effective treatment for all HCV genotypes.
Molecular Weight:
883
Purity:
99.91%
CAS Number:
[1377049-84-7]
Formula:
C49H54N8O8
Target:
HCV Protease|||SARS-CoV
T3334
* VAT and and shipping costs not included. Errors and price changes excepted
